Home > News > Too Little Bang for the Buck in Drug Research?
December 27th, 2006
Too Little Bang for the Buck in Drug Research?
"Researchers are tackling increasingly complex diseases using new tools—such as genomics, proteomics and nanotechnology—that will take years to bear fruit," says PhRMA Senior Vice President Ken Johnson, adding that "more than 2,000 new medicines are in development, including 646 medicines for cancer, 146 for heart disease and stroke, 77 for AIDS, and 56 for diabetes."
Stretching the limits on conducting wires July 25th, 2015
UT Dallas nanotechnology research leads to super-elastic conducting fibers July 24th, 2015
Nanopaper as an optical sensing platform July 23rd, 2015
Albany College of Pharmacy and Health Sciences to Host One Week Symposium on Nanomedicine July 23rd, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Smart hydrogel coating creates 'stick-slip' control of capillary action July 27th, 2015
Researchers predict material with record-setting melting point July 27th, 2015
Reshaping the solar spectrum to turn light to electricity: UC Riverside researchers find a way to use the infrared region of the sun's spectrum to make solar cells more efficient July 27th, 2015
Global Corrosion Resistant Nano Coatings Market To 2015: Acute Market Reports July 27th, 2015
Renishaw's inVia confocal Raman microscope system is being used in conservation activities at the Rijksmuseum in Amsterdam, the Netherlands June 16th, 2015
New sensing tech could help detect diseases, fraudulent art, chemical weapons June 1st, 2015
INSIDDE: Uncovering the real history of art using a graphene scanner May 21st, 2015
Winner Announced for NNI’s First ‘EnvisioNano’ Nanotechnology Image Contest May 6th, 2015